ALLG has been making an impact for patients with blood cancers for over five decades, through world-class clinical trial research that creates better treatments and better lives, while aiming for cure.
But we need to do more – each year, over 19,000 Australians and 2,000 New Zealanders will be diagnosed with a blood cancer like leukaemia, lymphoma and myeloma.
Blood cancer can develop in anyone, at any age, at any time, and there are no preventative health measures available like there are for other cancers.
With your help, our ALLG clinician Members are advancing research that tackles the biggest challenges of blood cancers.
We receive no ongoing funding and rely on the support of organisations and individuals just like you to support our essential blood cancer research.